BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12581699)

  • 1. NK-cell activity in immunotoxicity drug evaluation.
    Cederbrant K; Marcusson-Ståhl M; Condevaux F; Descotes J
    Toxicology; 2003 Apr; 185(3):241-50. PubMed ID: 12581699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tacrolimus Protopic.
    Lazarous MC; Kerdel FA
    Drugs Today (Barc); 2002 Jan; 38(1):7-15. PubMed ID: 12532181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flow-cytometric NK-cytotoxicity assay adapted for use in rat repeated dose toxicity studies.
    Marcusson-Ståhl M; Cederbrant K
    Toxicology; 2003 Dec; 193(3):269-79. PubMed ID: 14599763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Killer (NK) Cell Assays in Immunotoxicity Testing.
    Li Q
    Methods Mol Biol; 2018; 1803():231-241. PubMed ID: 29882143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell assays in immunotoxicity testing.
    Li Q
    Methods Mol Biol; 2010; 598():207-19. PubMed ID: 19967516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of natural killer cell subsets (two color analysis) and their activity in peripheral blood in inflammatory bowel disease.
    Hirata I; Hayashi K; Asada S; Miyoshi H; Iwakoshi K; Ohshiba S
    Bull Osaka Med Coll; 1990 Nov; 36(1-2):47-55. PubMed ID: 2135644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets.
    Cantrell DA; Robins RA; Brooks CG; Baldwin RW
    Immunology; 1982 Jan; 45(1):97-103. PubMed ID: 7056570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-based screening assay for Natural Killer cell activity.
    Blom WM; van Nielen WG; de Groene EM; Albers R
    Int Immunopharmacol; 2009 Jun; 9(6):746-52. PubMed ID: 19293002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo induction of lymphokine-activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy.
    Klasa RJ; Silver HK; Kong S
    Cancer Res; 1990 Aug; 50(16):4906-10. PubMed ID: 2379154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Modified NK Cell Degranulation Assay Applicable for Routine Evaluation of NK Cell Function.
    Shabrish S; Gupta M; Madkaikar M
    J Immunol Res; 2016; 2016():3769590. PubMed ID: 27413758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
    Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
    J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorescence NK assay using flow cytometry.
    McGinnes K; Chapman G; Marks R; Penny R
    J Immunol Methods; 1986 Jan; 86(1):7-15. PubMed ID: 3944470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid flow cytometry based cytotoxicity assay for evaluation of NK cell function.
    Mhatre S; Madkaikar M; Ghosh K; Desai M; Pujari V; Gupta M
    Indian J Exp Biol; 2014 Oct; 52(10):983-8. PubMed ID: 25345247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxicity of N,N-diethylaniline in mice: effect on natural killer activity, cytotoxic T lymphocyte activity, lymphocyte proliferation response and cellular components of the spleen.
    Li Q; Hirata Y; Piao S; Minami M
    Toxicology; 2000 Sep; 150(1-3):179-89. PubMed ID: 10996674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of natural killer cell function as a clinical assay.
    Hatam L; Schuval S; Bonagura VR
    Cytometry; 1994 May; 16(1):59-68. PubMed ID: 8033735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
    Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotoxicity evaluation of jet a jet fuel in female rats after 28-day dermal exposure.
    Mann CM; Peachee VL; Trimmer GW; Lee JE; Twerdok LE; White KL
    J Toxicol Environ Health A; 2008; 71(8):495-504. PubMed ID: 18338284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
    Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
    Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte subpopulations and natural killer activity in endometriosis.
    Iwasaki K; Makino T; Maruyama T; Matsubayashi H; Nozawa S; Yokokura T
    Int J Fertil Menopausal Stud; 1993; 38(4):229-34. PubMed ID: 8401682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.